201 related articles for article (PubMed ID: 33925823)
1. Methods for Identifying Microbial Natural Product Compounds that Target Kinetoplastid RNA Structural Motifs by Homology and De Novo Modeled 18S rRNA.
Mwangi HN; Muge EK; Wagacha PW; Ndakala A; Mulaa FJ
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925823
[TBL] [Abstract][Full Text] [Related]
2. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
3. Toward a Drug Against All Kinetoplastids: From LeishBox to Specific and Potent Trypanothione Reductase Inhibitors.
Ilari A; Genovese I; Fiorillo F; Battista T; De Ionna I; Fiorillo A; Colotti G
Mol Pharm; 2018 Aug; 15(8):3069-3078. PubMed ID: 29897765
[TBL] [Abstract][Full Text] [Related]
4. Screening a Natural Product-Based Library against Kinetoplastid Parasites.
Zulfiqar B; Jones AJ; Sykes ML; Shelper TB; Davis RA; Avery VM
Molecules; 2017 Oct; 22(10):. PubMed ID: 29023425
[TBL] [Abstract][Full Text] [Related]
5. The potential role of in silico approaches to identify novel bioactive molecules from natural resources.
Olğaç A; Orhan IE; Banoglu E
Future Med Chem; 2017 Sep; 9(14):1665-1686. PubMed ID: 28841048
[TBL] [Abstract][Full Text] [Related]
6. Kinetoplastid flagellates overlooked by universal primers dominate in the oxygenated hypolimnion of Lake Biwa, Japan.
Mukherjee I; Hodoki Y; Nakano S
FEMS Microbiol Ecol; 2015 Aug; 91(8):fiv083. PubMed ID: 26187480
[TBL] [Abstract][Full Text] [Related]
7. Interaction Networks of Ribosomal Expansion Segments in Kinetoplastids.
Vicens Q; Bochler A; Jobe A; Frank J; Hashem Y
Subcell Biochem; 2021; 96():433-450. PubMed ID: 33252739
[TBL] [Abstract][Full Text] [Related]
8. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.
Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781
[TBL] [Abstract][Full Text] [Related]
9. An updated view of kinetoplastid phylogeny using environmental sequences and a closer outgroup: proposal for a new classification of the class Kinetoplastea.
Moreira D; López-García P; Vickerman K
Int J Syst Evol Microbiol; 2004 Sep; 54(Pt 5):1861-1875. PubMed ID: 15388756
[TBL] [Abstract][Full Text] [Related]
10. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
Ambure P; Bhat J; Puzyn T; Roy K
J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Non-Peptidic Compounds against Chagas Disease Applying Pharmacophore Guided Molecular Modelling Approaches.
Rampogu S; Lee G; Baek A; Son M; Park C; Zeb A; Yoon SH; Park S; Lee KW
Molecules; 2018 Nov; 23(12):. PubMed ID: 30469538
[TBL] [Abstract][Full Text] [Related]
12. Post-transcriptional Modifications Modulate rRNA Structure and Ligand Interactions.
Jiang J; Seo H; Chow CS
Acc Chem Res; 2016 May; 49(5):893-901. PubMed ID: 27064497
[TBL] [Abstract][Full Text] [Related]
13. The cryo-EM Structure of a Novel 40S Kinetoplastid-Specific Ribosomal Protein.
Brito Querido J; Mancera-Martínez E; Vicens Q; Bochler A; Chicher J; Simonetti A; Hashem Y
Structure; 2017 Dec; 25(12):1785-1794.e3. PubMed ID: 29107485
[TBL] [Abstract][Full Text] [Related]
14.
Kwofie SK; Dankwa B; Odame EA; Agamah FE; Doe LPA; Teye J; Agyapong O; Miller WA; Mosi L; Wilson MD
Molecules; 2018 Jun; 23(7):. PubMed ID: 29954088
[TBL] [Abstract][Full Text] [Related]
15. The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations.
Ogungbe IV; Setzer WN
Molecules; 2016 Oct; 21(10):. PubMed ID: 27775577
[TBL] [Abstract][Full Text] [Related]
16. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV.
Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
J Biomol Struct Dyn; 2019 Jan; 37(1):131-146. PubMed ID: 29268664
[TBL] [Abstract][Full Text] [Related]
18. Neobodonids are dominant kinetoplastids in the global ocean.
Flegontova O; Flegontov P; Malviya S; Poulain J; de Vargas C; Bowler C; Lukeš J; Horák A
Environ Microbiol; 2018 Feb; 20(2):878-889. PubMed ID: 29266706
[TBL] [Abstract][Full Text] [Related]
19. Virtual screening for the discovery of bioactive natural products.
Rollinger JM; Stuppner H; Langer T
Prog Drug Res; 2008; 65():211, 213-49. PubMed ID: 18084917
[TBL] [Abstract][Full Text] [Related]
20. KISS: the kinetoplastid RNA editing sequence search tool.
Ochsenreiter T; Cipriano M; Hajduk SL
RNA; 2007 Jan; 13(1):1-4. PubMed ID: 17123956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
